BeyondSpring Inc/ KYG108301006 /
| 6/14/2024 10:00:00 PM | Chg. +0.1400 | Volume | Bid12:10:59 AM | Ask12:10:59 AM | High | Low |
|---|---|---|---|---|---|---|
| 2.6400USD | +5.60% | 102,671 Turnover: 259,747.7374 |
2.6000Bid Size: 200 | 2.8200Ask Size: 200 | 2.9300 | 2.5200 |
GlobeNewswire
5/16
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire
5/3
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...
GlobeNewswire
4/29
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
GlobeNewswire
3/25
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in...
GlobeNewswire
2/26
BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements
GlobeNewswire
1/10
BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K
GlobeNewswire
12/18/2023
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
GlobeNewswire
11/7/2023
BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of ...
GlobeNewswire
10/31/2023
BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Post...
GlobeNewswire
10/26/2023
SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degra...
GlobeNewswire
10/23/2023
SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors
GlobeNewswire
10/4/2023
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
GlobeNewswire
9/27/2023
BeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual Meeting
GlobeNewswire
9/7/2023
BeyondSpring to Participate in the R.W. Baird’s 2023 Global Healthcare Conference
GlobeNewswire
1/4/2022
Vaxxinity Appoints Jason Pesile as SVP, Finance & Accounting, and George Hornig to Board of Director...
GlobeNewswire
12/30/2021
BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
GlobeNewswire
12/15/2021
BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin’s Fast Onset Mechanis...
GlobeNewswire
12/10/2021
BeyondSpring Pharmaceuticals Announces Analysis of New Data on the Plinabulin/Pegfilgrastim Combinat...
GlobeNewswire
12/7/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BeyondSpring Inc...
GlobeNewswire
12/2/2021
BeyondSpring, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investor...
GlobeNewswire
12/1/2021
BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug ...
GlobeNewswire
11/24/2021
BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
